CN117835985A - 含有三磷酸腺苷(atp)的组合物及其用于认知功能的方法 - Google Patents

含有三磷酸腺苷(atp)的组合物及其用于认知功能的方法 Download PDF

Info

Publication number
CN117835985A
CN117835985A CN202280056829.6A CN202280056829A CN117835985A CN 117835985 A CN117835985 A CN 117835985A CN 202280056829 A CN202280056829 A CN 202280056829A CN 117835985 A CN117835985 A CN 117835985A
Authority
CN
China
Prior art keywords
atp
composition
administered
human
cognitive function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280056829.6A
Other languages
English (en)
Chinese (zh)
Inventor
J·拉特马克
L·科尔布
S·拜尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsi Usa LLC
Original Assignee
Tsi Usa LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsi Usa LLC filed Critical Tsi Usa LLC
Publication of CN117835985A publication Critical patent/CN117835985A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN202280056829.6A 2021-06-22 2022-06-22 含有三磷酸腺苷(atp)的组合物及其用于认知功能的方法 Pending CN117835985A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163213378P 2021-06-22 2021-06-22
US63/213,378 2021-06-22
PCT/US2022/034510 WO2022271813A1 (en) 2021-06-22 2022-06-22 Compositions containing adenosine triphosphate (atp) and methods of use for cognitive function

Publications (1)

Publication Number Publication Date
CN117835985A true CN117835985A (zh) 2024-04-05

Family

ID=84544774

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280056829.6A Pending CN117835985A (zh) 2021-06-22 2022-06-22 含有三磷酸腺苷(atp)的组合物及其用于认知功能的方法

Country Status (12)

Country Link
US (1) US20240299435A1 (https=)
EP (1) EP4358972A4 (https=)
JP (1) JP2024524288A (https=)
CN (1) CN117835985A (https=)
AU (1) AU2022297444A1 (https=)
CA (1) CA3224861A1 (https=)
CL (1) CL2023003882A1 (https=)
CO (1) CO2024000517A2 (https=)
EC (1) ECSP24004256A (https=)
MX (1) MX2024000145A (https=)
PE (1) PE20241617A1 (https=)
WO (1) WO2022271813A1 (https=)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20050261239A1 (en) * 2004-05-23 2005-11-24 Universiteit Van Maastricht Use of ATP for the manufacture of a medicament for treating certain inflammatory conditions, oxidative stress and fatigue
WO2008001494A1 (en) * 2006-06-27 2008-01-03 Kowa Co., Ltd. Pharmaceutical agent for prevention of fatigue and/or recovery from fatigue
US9522161B2 (en) * 2010-10-26 2016-12-20 Advanced Bio Development, Inc. Performance enhancing composition and method of delivering nutrients
PH12022550598A1 (en) * 2010-12-23 2024-03-11 Amazentis Sa Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders
US20140044690A1 (en) * 2012-08-08 2014-02-13 University Of South Florida High-Energy Compounds for Use in Alzheimer's and Other Neurodegenerative Diseases
US10092590B2 (en) * 2012-09-10 2018-10-09 Metabolic Technologies, Inc. Composition of HMB and ATP and methods of use
WO2014106860A2 (en) * 2013-01-03 2014-07-10 Laila Nutraceuticals Synergistic dietary supplement compositions for enhancing physical performance and energy levels
US10888576B2 (en) * 2018-10-08 2021-01-12 Metabolic Technologies, Inc. Composition of HMB and ATP and methods of use
BR112022004108A2 (pt) * 2019-09-05 2022-05-31 Tsi Group Ltd Métodos para aprimorar a absorção gastrointestinal e utilização sistêmica de materiais nutricionais, para aumentar a biodisponibilidade de um material nutricional em um animal e para aprimorar a absorção de um material nutricional em ser humano

Also Published As

Publication number Publication date
JP2024524288A (ja) 2024-07-05
PE20241617A1 (es) 2024-08-07
WO2022271813A1 (en) 2022-12-29
EP4358972A4 (en) 2025-04-16
CA3224861A1 (en) 2022-12-29
CO2024000517A2 (es) 2024-05-10
AU2022297444A1 (en) 2024-01-18
CL2023003882A1 (es) 2024-07-05
MX2024000145A (es) 2024-03-22
EP4358972A1 (en) 2024-05-01
ECSP24004256A (es) 2024-02-29
US20240299435A1 (en) 2024-09-12

Similar Documents

Publication Publication Date Title
Lambert et al. Effects of carbohydrate feeding on multiple-bout resistance exercise
Gonzalez et al. Effect of a pre-workout energy supplement on acute multi-joint resistance exercise
TWI654936B (zh) 米蛋白補充物及其使用方法
Hoffman et al. Effect of nutritionally enriched coffee consumption on aerobic and anaerobicexercise performance
US20210186077A1 (en) Rice protein supplement and methods of use thereof
US20160303177A1 (en) Nutritional supplement
MX2012005646A (es) Metodo para mejorar la sintesis de proteinas del musculo.
US20160303176A1 (en) Nutritional supplement
Fukuda et al. The possible combinatory effects of acute consumption of caffeine, creatine, and amino acids on the improvement of anaerobic running performance in humans
US12251393B2 (en) Compositions containing adenosine triphosphate (ATP) and methods of use
Wismanadi et al. Glutamine accelerates post-exercise recovery of arms power, leg power, and smash velocity at 48 hours for non-elite badminton athletes
Rivera et al. Acute effect of caffeine supplementation on neuromuscular performance and repeated-sprint ability in wheelchair rugby players: a case study
CN117835985A (zh) 含有三磷酸腺苷(atp)的组合物及其用于认知功能的方法
RU2848641C1 (ru) Способ повышения общей физической работоспособности спортсменов, специализирующихся в игровых видах спорта
Bezuglov et al. Citrulline in elite sports: is there a point?
AU2005296915A1 (en) Nutrient supplement and use of the same
TO et al. OP-PN14 Ergogenic Aids II
Amin et al. The effect of glutamine and glucose supplementation on maximal aerobic power and hemoglobin concentration in athlete young girls
Sakong Effect of beetroot juice supplementation on aerobic and anaerobic capacities, and isokinetic muscle functions in power athletes
Smolka et al. Caffeine intake enhances endurance performance in sub-elite but not in elite athletes
Mills The Effect of a Bcaa Supplement with and without Cho on Performance in Recreationally Trained Cyclists
reza Seyedi Effects of High Intensity Interval Training on Anaerobic Performance & Aerobic Power on Male Basketball Players: 3137 Board# 6 June 2 8: 00 AM-9: 30 AM
Fujie et al. Chlorella Intake Further Enhances Anaerobic And Aerobic Capacities Increased By High Intensity Intermittent Training: 3135 Board# 4 June 2 800 AM-930 AM
Chetlin The effects of resistance training and oral creatine supplementation on muscle fiber morphology, strength and activities of daily living in patients with Charcot-Marie-Tooth disease
Vukovic User's Guide to Women's Health Supplements

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination